WorldMEN 2025: 19th International Workshop on Multiple Endocrine Neoplasia and other Rare Endocrine Tumors
Endocrine-Related Cancer is excited to announce its new special collection in collaboration with WorldMEN 2025 - 19th International Workshop on Multiple Endocrine Neoplasia and other Rare Endocrine Tumors (16-17 June 2025, São Paulo, Brazil). The Collection Editors invite submissions of original research, mini review and review articles from speakers and delegates attending the workshop, along with complementary work from outside the meeting.
The first Multiple Endocrine Neoplasia (MEN) meeting took place in Canada in 1984. At that time, the aim of the meeting was to engage the scientific community, including the world experts in MEN, to collaborate in the discovery of the genes involved in MEN syndromes. This effort led to the discovery of the RET and MEN1 genes. Since then, the focus of the meeting has broadened to cover other neuroendocrine tumors that are sporadic or associated with hereditary syndromes.
The 2025 meeting will be held in São Paulo, Brazil, with an exceptional programme exploring the latest research on pituitary, adrenal, parathyroid, thyroid, and pancreatic neuroendocrine tumors, from basic science to the latest advances in diagnosis and treatment.
As a multidisciplinary meeting, the workshop will involve basic scientists, geneticists, endocrinologists, oncologists, surgeons, pathologists, gastroenterologists, radiologists, and nuclear medicine physicians with the goal to update current knowledge, discuss ongoing challenges, and define new diagnostic and treatment requirements.
In this special collection, we hope to highlight the important topics discussed in the meeting.
For more information and to submit your proposal, please email erc@bioscientifica.com. Please note, the Editors will consider proposals from researchers who did not attend the event but who work in this important field.
Collection Editors
|
|
Dr Ana O. Hoff Dr Ana Hoff is chief of Endocrine Oncology at Instituto do Cancer do Estado de São Paulo (ICESP), University of São Paulo Medical School since 2010. Dr Ana Hoff completed her fellowship in Endocrinology and Metabolism at the combined program Baylor College of Medicine/UT MD Anderson Cancer Center, Houston TX. Before joining the faculty at the Endocrinology Department from University of São Paulo sheworked at the University of Texas MD Anderson Cancer Center in Houston Texas as an Assistant Professor of Medicine. Dr Hoff’s clinical and research interests include differentiated and medullary thyroid cancer, multiple endocrine neoplasia syndromes, neuroendocrine tumors and disorders of bone metabolism. Dr Hoff has been an active member of the American Thyroid Association, International Thyroid Oncology Group, International Committee of World MEN Meeting, Endocrine Society, Latin America Thyroid Society and Sociedade Brasileira de Endocrinologia e Metabolismo. |
|
|
Associate Professor Madson Q. Almeida Associate Professor of Endocrinology and Metabolism, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo (FMUSP). Head of the Laboratory of Cellular and Molecular Endocrinology (LIM25). Currently, Principal Investigator for two thematic FAPESP projects:1) Clinical and genetic aspects of endocrine hypertension.2) Collaborative project with the Institute of Technology at the University of Zurich (ETH) on Interstitial Monitoring of Steroids.International Groups and Society Activities:Chair of the Study Group on Pheochromocytomas and Paragangliomas of The American Australian Asian Adrenal Alliance (A5).President of the Adrenal and Hypertension Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) (20212024).Member of the International Commission of SBEM (20252027). Medical Positions:Attending Physician at the Adrenal Unit, Division of Endocrinology and Metabolism, Hospital das Clínicas, FMUSP.Physician at the São Paulo State Cancer Institute (ICESP), Hospital das Clínicas, FMUSP.Research Focus: Primarily works in the field of Endocrinology and Metabolism, with emphasis on: Endocrine hypertension (primary aldosteronism, pheochrocytoma/paraganglioma). Endocrine oncology (pheochromocytoma, paraganglioma, adrenal cortex tumors, and thyroid cancer). Cushing syndrome. Molecular genetics of adrenal diseases. |
|
Dr Maria Luisa Brandi Professor of Endocrinology, University of San Raffaele, Milan, Italy I am currently the Director of the FirmoLab basic Laboratory at the Stabilimento Chimico Farmaceutico Militare, Florence, Italy. |
